We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Union has drafted a resolution calling on the World Health Organization to create a shared pool of intellectual property rights for vaccines and treatments during the coronavirus pandemic. Read More
Reports of positive early results from a COVID-19 trial of Gilead’s antiviral drug remdesivir in Chicago are premature, according to the University of Chicago Medicine and Biological Sciences. Read More
Novo Nordisk yesterday offered free insulin for 90 days to patients who have lost their healthcare benefits because of the COVID-19 pandemic. If a patient’s Medicaid benefits are denied, assistance can be extended until the end of the year, the company said. Read More
As the desperate search for a COVID-19 treatment continues, two phase 3 trials in China of Gilead’s remdesivir as a treatment have been suspended due to the lack of eligible patients. Meanwhile, multiple trials of the drug in the U.S. and Europe are going forward. Read More